StocksFin Logo
AbCellera Biologics Inc. country of incorporation
|
|
Dr. Carl L. Hansen
|
475 employees
NASDAQ | Healthcare | Biotechnology
PTC Therapeutics, Inc. country of incorporation
|
|
Dr. Stuart Peltz
|
1,167 employees
NASDAQ | Healthcare | Biotechnology
Q322 reported Nov 8, 2022 Reporting Period
$101.38M 1740.6% vs. Q321 Revenues Q322
85.17% -14.8% vs. Q321 Gross Profit Margin
26.26% 106.8% vs. Q321 Net Profit Margin
-141.3M ! -2282% vs. Q321 Free Cash Flow Q322
$0.09 212.5% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Q322 reported Oct 27, 2022 Reporting Period
$217.13M 56.5% vs. Q321 Revenues Q322
93.55% -1.8% vs. Q321 Gross Profit Margin
-50.35% ! 47.7% vs. Q321 Net Profit Margin
-64.07M ! -25.2% vs. Q321 Free Cash Flow Q322
$-1.53 ! 19% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
9.19
0.98
Current Ratio
9.86
1.23
Cash Ratio
3.51
0.25
Price to Book
2.26
-15.85
Price to Sales
27.83
16.57
Price to Earnings
26.5
-8.23